SCOPUS 정보 검색 플랫폼

Journal of the American Heart Association

Volumn 7, Issue 5, 2018, Pages

Safety of perioperative aprotinin administration during isolated coronary artery bypass graft surgery: Insights from the ART (Arterial Revascularization Trial)

(263) Benedetto, Umberto a Altman, Douglas G b Gerry, Stephen b Gray, Alastair b Lees, Belinda b Angelini, Gianni D a Flather, Marcus c,d Taggart, David P b Ratnatunga, C c Westaby, S c Cook, J c Wallis, C c Wos, S c Jasinski, M c Widenka, K c Blach, A c Gocol, R c Hudziak, D c Zurek, P c Deja, M c more..

a UNIVERSITY OF BRISTOL (United Kingdom)

b UNIVERSITY OF OXFORD (United Kingdom)

c UNIVERSITY OF EAST ANGLIA (United Kingdom)

d NORFOLK AND NORWICH UNIVERSITY HOSPITAL (United Kingdom)

Author keywords

Aprotinin; Coronary artery bypass graft surgery; Outcomes; Propensity score matching; Surgery

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; APROTININ; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN; HEMOSTATIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; ALL CAUSE MORTALITY; ARTICLE; CARDIOVASCULAR PROCEDURE; CLINICAL OUTCOME; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; FEMALE; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITAL CARE; HOSPITAL MORTALITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY RISK; PERIOPERATIVE PERIOD; POST HOC ANALYSIS; PRIORITY JOURNAL; REPEAT PROCEDURE; SURVIVAL TIME; ADVERSE EVENT; AGED; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY (TOPIC); OPERATIVE BLOOD LOSS; POSTOPERATIVE HEMORRHAGE; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

AGED; APROTININ; BLOOD LOSS, SURGICAL; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMOSTATICS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PERIOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85042686356 PISSN: None EISSN: 20479980 Source Type: Journal
DOI: 10.1161/JAHA.117.007570 Document Type: Article

Times cited : (17)

References (21)

1
- 15744382964
- Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery
- Kuduvalli M, Oo AY, Newall N, Grayson AD, Jackson M, Desmond MJ, Fabri BM, Rashid A. Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery. Eur J Cardiothorac Surg. 2005;27:592-598
- (2005) Eur J Cardiothorac Surg , vol.27 , pp. 592-598
- Kuduvalli, M.¹ Oo, A.Y.² Newall, N.³ Grayson, A.D.⁴ Jackson, M.⁵ Desmond, M.J.⁶ Fabri, B.M.⁷ Rashid, A.⁸

2
- 31344467254
- The risk associated with aprotinin in cardiac surgery
- Mangano DT, Tudor IC, Dietzel C; Multicenter Study of Perioperative Ischemia Research Group, Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354:353-365
- (2006) N Engl J Med , vol.354 , pp. 353-365
- Mangano, D.T.¹ Tudor, I.C.² Dietzel, C.³

3
- 39549100109
- Aprotinin during coronary artery bypass grafting and risk of death
- Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary artery bypass grafting and risk of death. N Engl J Med. 2008;358:771-783
- (2008) N Engl J Med , vol.358 , pp. 771-783
- Schneeweiss, S.¹ Seeger, J.D.² Landon, J.³ Walker, A.M.⁴

4
- 39549099909
- The effect of aprotinin on outcome after coronary-artery bypass grafting
- Shaw AD, Stafford-Smith M, White WD, Phillips-Bute B, Swaminathan M, Milano C, Welsby IJ, Aronson S, Mathew JP, Peterson ED, Newman MF. The effect of aprotinin on outcome after coronary-artery bypass grafting. N Engl J Med. 2008;358:784-793
- (2008) N Engl J Med , vol.358 , pp. 784-793
- Shaw, A.D.¹ Stafford-Smith, M.² White, W.D.³ Phillips-Bute, B.⁴ Swaminathan, M.⁵ Milano, C.⁶ Welsby, I.J.⁷ Aronson, S.⁸ Mathew, J.P.⁹ Peterson, E.D.¹⁰ Newman, M.F.¹¹

5
- 44349089188
- A comparison of aprotinin and lysine analogues in high-risk cardiac surgery
- Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussiéres JS, Coté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319-2331
- (2008) N Engl J Med , vol.358 , pp. 2319-2331
- Fergusson, D.A.¹ Hébert, P.C.² Mazer, C.D.³ Fremes, S.⁴ MacAdams, C.⁵ Murkin, J.M.⁶ Teoh, K.⁷ Duke, P.C.⁸ Arellano, R.⁹ Blajchman, M.A.¹⁰ Bussiéres, J.S.¹¹ Coté, D.¹² Karski, J.¹³ Martineau, R.¹⁴ Robblee, J.A.¹⁵ Rodger, M.¹⁶ Wells, G.¹⁷ Clinch, J.¹⁸ Pretorius, R.¹⁹

6
- 33846885901
- Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery
- Mangano DT, Miao Y, Vuylsteke A, Tudor IC, Juneja R, Filipescu D, Hoeft A, Fontes ML, Hillel Z, Ott E, Titov T, Dietzel C, Levin J. Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA. 2007;297:471-479
- (2007) JAMA , vol.297 , pp. 471-479
- Mangano, D.T.¹ Miao, Y.² Vuylsteke, A.³ Tudor, I.C.⁴ Juneja, R.⁵ Filipescu, D.⁶ Hoeft, A.⁷ Fontes, M.L.⁸ Hillel, Z.⁹ Ott, E.¹⁰ Titov, T.¹¹ Dietzel, C.¹² Levin, J.¹³

7
- 85042719174
- Accessed September 18, 2013
- European Medicines Agency. 2013. http://www.ema.europa.eu/docs/en_ GB/document_library/Referrals_document/Antifibrinolytic_medicines/ WC500122922.pdf. Accessed September 18, 2013
- (2013)

8
- 85042705737
- Accessed September 18, 2013
- European Medicines Agency. 2013. http://www.ema.europa.eu/docs/en_ GB/document_library/Referrals_document/Antifibrinolytic_medicines/ WC500122924.pdf. Accessed September 18, 2013
- (2013)

9
- 85007396820
- Randomized trial of bilateral versus single internal-thoracic-artery grafts
- Taggart DP, Altman DG, Gray AM, Lees B, Gerry S, Benedetto U, Flather M. Randomized trial of bilateral versus single internal-thoracic-artery grafts. N Engl J Med. 2016;375:2540-2549
- (2016) N Engl J Med , vol.375 , pp. 2540-2549
- Taggart, D.P.¹ Altman, D.G.² Gray, A.M.³ Lees, B.⁴ Gerry, S.⁵ Benedetto, U.⁶ Flather, M.⁷

10
- 33751205161
- Protocol for the Arterial Revascularisation Trial (ART): a randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265]
- Taggart DP, Lees B, Gray A, Altman DG, Flather M, Channon K. Protocol for the Arterial Revascularisation Trial (ART): a randomised trial to compare survival following bilateral versus single internal mammary grafting in coronary revascularisation [ISRCTN46552265]. Trials. 2006;7:7
- (2006) Trials , vol.7 , pp. 7
- Taggart, D.P.¹ Lees, B.² Gray, A.³ Altman, D.G.⁴ Flather, M.⁵ Channon, K.⁶

11
- 84864808953
- KDIGO clinical practice guidelines for acute kidney injury
- Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-c184
- (2012) Nephron Clin Pract , vol.120 , pp. c179-c184
- Khwaja, A.¹

12
- 0003738155
- New York, NY: J Wiley & Sons
- Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: J Wiley & Sons; 1987
- (1987) Multiple Imputation for Nonresponse in Surveys
- Rubin, D.B.¹

13
- 79951791644
- A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality
- Austin PC. A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality. Multivariate Behav Res. 2011;46:119-151
- (2011) Multivariate Behav Res , vol.46 , pp. 119-151
- Austin, P.C.¹

14
- 1542532754
- A proportional hazards model for the subdistribution of a competing risk
- Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509
- (1999) J Am Stat Assoc , vol.94 , pp. 496-509
- Fine, J.P.¹ Gray, R.J.²

15
- 84871238644
- Putting the record straight on aprotinin as safe and effective: results from a mixed treatment metaanalysis of trials of aprotinin
- Howell N, Senanayake E, Freemantle N, Pagano D. Putting the record straight on aprotinin as safe and effective: results from a mixed treatment metaanalysis of trials of aprotinin. J Thorac Cardiovasc Surg. 2012;145:234-240
- (2012) J Thorac Cardiovasc Surg , vol.145 , pp. 234-240
- Howell, N.¹ Senanayake, E.² Freemantle, N.³ Pagano, D.⁴

16
- 84891760118
- Accessed May 4, 2012
- US Food and Drug Administration. Information for healthcare professionals: aprotinin injection (marketed as trasylol) 2010. Available at: https://www.fda. gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ ucm142720.htm. Accessed May 4, 2012
- Information for healthcare professionals: aprotinin injection (marketed as trasylol) 2010

17
- 34748882511
- Aprotinin does not increase the risk of renal failure in cardiac surgery patients
- Furnary AP, Wu YX, Hiratzka LF, Grunkemeier GL, Page US. Aprotinin does not increase the risk of renal failure in cardiac surgery patients. Circulation. 2007;116:I-127-I-133
- (2007) Circulation , vol.116 , pp. I-127
- Furnary, A.P.¹ Wu, Y.X.² Hiratzka, L.F.³ Grunkemeier, G.L.⁴ Page, U.S.⁵

18
- 85042730393
- Accessed August 18
- FDA Cardiology and Renal Drugs Advisory Committee. Trasylol (aprotinin injection) risk benefit review 2006. Available at: https://www.fda.gov/ ohrms/dockets/ac/06/slides/2006-4234S3-01-Bayer.pdf Accessed August 18, 2012
- (2012) Trasylol (aprotinin injection) risk benefit review 2006

19
- 85042701296
- Accessed August 18
- Trasylolw (aprotinin injection) briefing document 2007. Available at: https:// www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4316b1-03-BAYER.pdf Accessed August 18, 2012
- (2012) Trasylolw (aprotinin injection) briefing document 2007

20
- 84877762400
- Accessed July 8, 2012
- Health Canada. Final report-expert advisory panel on Trasylol (aprotinin) 2011 http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2011/ 13544a-eng.php. Accessed July 8, 2012
- (2011) Final report-expert advisory panel on Trasylol (aprotinin)

21
- 4444380033
- Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials
- Sedrakyan A, Treasure T, Elefteriades JA. Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. J Thorac Cardiovasc Surg. 2004;128:442-448
- (2004) J Thorac Cardiovasc Surg , vol.128 , pp. 442-448
- Sedrakyan, A.¹ Treasure, T.² Elefteriades, J.A.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.